PRESSLINE IPA 99% PURE

SECTION 2: Hazards identification

HMIS® ratings

Health 1 Flammability 3 Reactivity 0 This product falls under the following

Principle Routes of Exposure

Target Organs Eye contact, Skin contact, Inhalation Skin, Respiratory Tract, Eyes, Central Nervous System

Medical Conditions Generally Aggravated by Exposure

Respiratory disease including asthma and bronchitis Immediate (Acute) Health Effects by Route of Exposure Inhalation Can cause minor respiratory irritation, dizziness, weakness, fatigue, nausea, and headache. Irritation may be delayed for several hours. Skin Contact: Eye Contact Can cause minor skin irritation, defatting, and dermatitis. Can cause moderate/severe irritation, tearing and reddening, but not likely to permanently injure eye tissue. Temporary vision impairment (cloudy or blurred vision) is possible. Ingestion Irritating to mouth, throat, and stomach. Can cause abdominal discomfort, nausea, vomiting and diarrhea. Long-Term (Chronic) Health Effects Reproductive and Developmental No data available to indicate product or any components present at greater than 0.1% may cause birth defects. Mutagenicity No data available to indicate product or any components present at greater than 0.1% is mutagenic or genotoxic. Inhalation Upon prolonged and/or repeated exposure, can cause minor respiratory irritation, dizziness, weakness, fatigue, nausea, and headache. Skin Contact Upon prolonged or repeated contact, can cause minor skin irritation, defatting, and dermatitis. Ingredients of this product appear on the following